Earlier this month, Portola Pharmaceuticals took a hit when the FDA swatted down its reversal agent candidate for next-gen anticoagulants--and the makers of those ant...

“The Eagle” Offers Quality, Precision & Performance in a Compact Footprint Quincy, MA – Maruho Hatsujyo Innovations (MHI) – the U.S. subsidiary of Kyoto-based Mar...